Detailed Information on Publication Record
2012
Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2
LUKÁŠ, Zdeněk, Martin FALK, Josef FEIT, Ondřej SOUČEK, Iva FALKOVÁ et. al.Basic information
Original name
Sequestration of MBNL1 in tissues of patients with myotonic dystrophy type 2
Authors
LUKÁŠ, Zdeněk (203 Czech Republic, guarantor, belonging to the institution), Martin FALK (203 Czech Republic), Josef FEIT (203 Czech Republic), Ondřej SOUČEK (203 Czech Republic), Iva FALKOVÁ (203 Czech Republic), Lenka ŠTEFANČÍKOVÁ (203 Czech Republic), Eva JANOUŠOVÁ (203 Czech Republic, belonging to the institution), Lenka FAJKUSOVÁ (203 Czech Republic), Jana ZAORÁLKOVÁ (203 Czech Republic) and Renata HRABÁLKOVÁ (56 Belgium)
Edition
Neuromuscular Disorders, London, Elsevier, 2012, 0960-8966
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30000 3. Medical and Health Sciences
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.464
RIV identification code
RIV/00216224:14740/12:00060646
Organization unit
Central European Institute of Technology
UT WoS
000306539100005
Keywords in English
Myotonic dystrophy; Transcription of ZNF9; CCUG repeat expansion; Sequestration of MBNL1 protein; Ribonuclear foci; Insulin receptor alternative splicing
Tags
Tags
International impact
Změněno: 23/4/2013 07:45, Olga Křížová
Abstract
V originále
The pathogenesis of myotonic dystrophy type 2 includes the sequestration of MBNL proteins by expanded CCUG transcripts, which leads to an abnormal splicing of their target pre-mRNAs. We have found CCUG(exp) RNA transcripts of the ZNF9 gene associated with the formation of ribonuclear foci in human skeletal muscle and some non-muscle tissues present in muscle biopsies and skin excisions from myotonic dystrophy type 2 patients. Using RNA-FISH and immunofluorescence-FISH methods in combination with a high-resolution confocal microscopy, we demonstrate a different frequency of nuclei containing the CCUG(exp) foci, a different expression pattern of MBNL1 protein and a different sequestration of MBNL1 by CCUG(exp) repeats in skeletal muscle, vascular smooth muscle and endothelia, Schwann cells, adipocytes, and ectodermal derivatives. The level of CCUG(exp) transcription in epidermal and hair sheath cells is lower compared with that in other tissues examined. We suppose that non-muscle tissues of myotonic dystrophy type 2 patients might be affected by a similar molecular mechanism as the skeletal muscle, as suggested by our observation of an aberrant insulin receptor splicing in myotonic dystrophy type 2 adipocytes.